These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 27053532)
1. A genome editing primer for the hematologist. Hoban MD; Bauer DE Blood; 2016 May; 127(21):2525-35. PubMed ID: 27053532 [TBL] [Abstract][Full Text] [Related]
2. Welcoming a new age for gene therapy in hematology. Weiss MJ; Mullighan CG Blood; 2016 May; 127(21):2523-4. PubMed ID: 27053534 [TBL] [Abstract][Full Text] [Related]
3. Application of genome editing technologies to the study and treatment of hematological disease. Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620 [TBL] [Abstract][Full Text] [Related]
4. Ethical and regulatory aspects of genome editing. Kohn DB; Porteus MH; Scharenberg AM Blood; 2016 May; 127(21):2553-60. PubMed ID: 27053531 [TBL] [Abstract][Full Text] [Related]
5. The clinical applications of genome editing in HIV. Wang CX; Cannon PM Blood; 2016 May; 127(21):2546-52. PubMed ID: 27053530 [TBL] [Abstract][Full Text] [Related]
6. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles. Yu KR; Natanson H; Dunbar CE Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988 [TBL] [Abstract][Full Text] [Related]
7. At the Heart of Genome Editing and Cardiovascular Diseases. Hernandez-Benitez R; Martinez-Martinez ML; Lajara J; Magistretti P; Montserrat N; Izpisua Belmonte JC Circ Res; 2018 Jul; 123(2):221-223. PubMed ID: 29976689 [No Abstract] [Full Text] [Related]
8. Therapeutic editing of hepatocyte genome in vivo. Ruiz de Galarreta M; Lujambio A J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665 [TBL] [Abstract][Full Text] [Related]
9. Customizing the genome as therapy for the β-hemoglobinopathies. Canver MC; Orkin SH Blood; 2016 May; 127(21):2536-45. PubMed ID: 27053533 [TBL] [Abstract][Full Text] [Related]
10. DNA nicks promote efficient and safe targeted gene correction. Davis L; Maizels N PLoS One; 2011; 6(9):e23981. PubMed ID: 21912657 [TBL] [Abstract][Full Text] [Related]
11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
12. Various strategies of effector accumulation to improve the efficiency of genome editing and derivative methodologies. Kunii A; Yamamoto T; Sakuma T In Vitro Cell Dev Biol Anim; 2020 May; 56(5):359-366. PubMed ID: 32514717 [TBL] [Abstract][Full Text] [Related]
14. Acceleration of cancer science with genome editing and related technologies. Sakuma T; Yamamoto T Cancer Sci; 2018 Dec; 109(12):3679-3685. PubMed ID: 30315615 [TBL] [Abstract][Full Text] [Related]
15. [Mouse models of hematological diseases using genome editing technology]. Nagamachi A; Inaba T Rinsho Ketsueki; 2022; 63(11):1551-1557. PubMed ID: 36476797 [TBL] [Abstract][Full Text] [Related]
16. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish. Kawahara A; Hisano Y; Ota S; Taimatsu K Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic gene editing in haematological disorders with CRISPR/Cas9. Jensen TI; Axelgaard E; Bak RO Br J Haematol; 2019 Jun; 185(5):821-835. PubMed ID: 30864164 [TBL] [Abstract][Full Text] [Related]
18. Genome Editing for Cardiovascular Diseases-A Brief Review for Cardiologists. Hagiwara N Am J Cardiol; 2019 Mar; 123(6):1002-1006. PubMed ID: 30606452 [TBL] [Abstract][Full Text] [Related]
19. Harnessing natural DNA modifying activities for editing of the genome and epigenome. DeNizio JE; Schutsky EK; Berrios KN; Liu MY; Kohli RM Curr Opin Chem Biol; 2018 Aug; 45():10-17. PubMed ID: 29452938 [TBL] [Abstract][Full Text] [Related]
20. Scientists Correct a Pathogenic Gene Mutation in Human Embryos. Hampton T Circulation; 2017 Oct; 136(15):1449-1450. PubMed ID: 28993374 [No Abstract] [Full Text] [Related] [Next] [New Search]